Roelof Botha, Lead Independent Director Of Natera Board, Makes $5 Million Investment In Natera

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced that Roelof Botha, lead independent director of Natera's board of directors and partner at Sequoia Capital, has invested $5 million to purchase shares of Natera's stock on the open market.